side-by-side comparison of cardiac ct scans, with and without ai enhancements
Representative non-contrast computed tomography slice (left), with super-imposed segmentations (right). One artificial intelligence (AI) model was used to segment a cardiac mask (magenta line) and coronary artery calcium (red). A second AI model segmented left ventricular myocardium (purple), left atrial (green), left ventricle (light red), right ventricle (blue) and right atrial (yellow) volumes.

Image source: Miller RJH et al., Nature Communications 2024 (CC BY 4.0)

News • Cardiovascular disease detection

Routine chest CT with AI to assess CVD risk

A recent study designed and implemented by investigators at Cedars-Sinai found that artificial intelligence (AI) can accurately evaluate cardiovascular risk during a routine chest computed tomography (CT) scan without contrast.

This imaging method, which measures coronary calcium and sizes of heart chambers and heart muscle, could make identifying cardiovascular risk less expensive and less invasive. The findings were published in the peer-reviewed journal Nature Communications

portrait of Piotr Slomka
Piotr Slomka, PhD

Image source: Cedars-Sinai

“These results are likely practice-changing for many patients because this technology can accurately identify cardiovascular risk without the use of invasive tests or contrast dye that some patients cannot receive,” said Piotr J. Slomka, PhD, director of Innovation in Imaging at Cedars-Sinai, professor of Medicine in the Division of Artificial Intelligence in Medicine and senior author of the study. 

Slomka, a professor of Cardiology in the Department of Cardiology in the Smidt Heart Institute at Cedars-Sinai, said that more than 15 million CT scans are performed in the U.S. each year— and many of these are underutilized or understudied. Clinicians currently can evaluate cardiovascular risk using a CT scan, but usually with contrast. “This novel AI algorithm makes it possible to get crucial heart health insights from cheaper scans that use less radiation, potentially making detailed heart evaluations part of regular diagnostic procedures,” Slomka said.

portrait of Sumeet Chugh
Sumeet Chugh, MD

Image source: Cedars-Sinai

Investigators incorporated two artificial intelligence models to evaluate data on coronary calcium and heart muscle chamber sizes from nearly 30,000 patient imaging records. They were able to determine that those measures are a better indicator of cardiac risk than a radiologist’s identification of abnormalities. 

Sumeet Chugh, MD, director of the Division of Artificial Intelligence in Medicine, who was not involved in the study, says this technology allows for large-scale use of existing CT data to spot individuals at risk sooner. “Coronary artery disease is the leading cause of disability and death at a global level,” said Chugh, associate director of the Smidt Heart Institute. “These findings highlight how AI tools could leverage existing CT images performed for lung disease investigation, to make a cost-effective, public health impact on heart disease.” 

The collective group of Cedars-Sinai investigators that developed these findings also included teams from the Smidt Heart Institute, the Biomedical Imaging Research Institute and the Department of Biomedical Sciences. 

Source: Cedars-Sinai


Read all latest stories

Related articles


News • Classification for coronary artery disease

Study: Photon-counting CT improves CAD assessment

Higher image quality, better spatial resolution: A new radiology study demonstrates how photon-counting CT imaging can improve evaluation of coronary artery disease.


News • Congenital heart defect diagnosis

Photon-counting CT improves cardiac imaging in babies

A new advanced form of CT imaging offers better cardiovascular imaging quality compared to dual-source CT (DSCT) in infants with suspected cardiac heart defects, according to a new study.


News • CT-Derived Functional Imaging

CTFI: Enabling CT lung diagnosis without contrast

Diagnosing lung conditions such as pulmonary embolism is more challengenging when a patient cannot tolerate contrast agents. Now, a new software solution is addressing the issue.

Related products

Subscribe to Newsletter